Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Nonsteroidal Anti-Inflammatory Drug
1.2.3 Disease-Modifying Antirheumatic Drug
1.2.4 Biologic Drug
1.2.5 Enzyme Inhibitor
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis Therapeutics Market Perspective (2018-2033)
2.2 Psoriatic Arthritis Therapeutics Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Psoriatic Arthritis Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Psoriatic Arthritis Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Psoriatic Arthritis Therapeutics Market Dynamics
2.3.1 Psoriatic Arthritis Therapeutics Industry Trends
2.3.2 Psoriatic Arthritis Therapeutics Market Drivers
2.3.3 Psoriatic Arthritis Therapeutics Market Challenges
2.3.4 Psoriatic Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Therapeutics Revenue
3.4 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Revenue in 2022
3.5 Psoriatic Arthritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis Therapeutics Breakdown Data by Type
4.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2024-2033)
5 Psoriatic Arthritis Therapeutics Breakdown Data by Application
5.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Psoriatic Arthritis Therapeutics Market Size (2018-2033)
6.2 North America Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023)
6.4 North America Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Market Size (2018-2033)
7.2 Europe Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023)
7.4 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis Therapeutics Market Size (2018-2033)
9.2 Latin America Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis Therapeutics Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Psoriatic Arthritis Therapeutics Introduction
11.2.4 Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Psoriatic Arthritis Therapeutics Introduction
11.3.4 Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Introduction
11.4.4 Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Psoriatic Arthritis Therapeutics Introduction
11.5.4 Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Detail
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Introduction
11.7.4 Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.7.5 Janssen Biotech Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Psoriatic Arthritis Therapeutics Introduction
11.8.4 Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.8.5 Amgen Recent Development
11.9 UCB
11.9.1 UCB Company Detail
11.9.2 UCB Business Overview
11.9.3 UCB Psoriatic Arthritis Therapeutics Introduction
11.9.4 UCB Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.9.5 UCB Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriatic Arthritis Therapeutics Introduction
11.10.4 AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023)
11.10.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Nonsteroidal Anti-Inflammatory Drug
Table 3. Key Players of Disease-Modifying Antirheumatic Drug
Table 4. Key Players of Biologic Drug
Table 5. Key Players of Enzyme Inhibitor
Table 6. Global Psoriatic Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Psoriatic Arthritis Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Psoriatic Arthritis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Psoriatic Arthritis Therapeutics Market Share by Region (2018-2023)
Table 10. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Psoriatic Arthritis Therapeutics Market Share by Region (2024-2033)
Table 12. Psoriatic Arthritis Therapeutics Market Trends
Table 13. Psoriatic Arthritis Therapeutics Market Drivers
Table 14. Psoriatic Arthritis Therapeutics Market Challenges
Table 15. Psoriatic Arthritis Therapeutics Market Restraints
Table 16. Global Psoriatic Arthritis Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Psoriatic Arthritis Therapeutics Market Share by Players (2018-2023)
Table 18. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2022)
Table 19. Ranking of Global Top Psoriatic Arthritis Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Psoriatic Arthritis Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
Table 23. Date of Enter into Psoriatic Arthritis Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriatic Arthritis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2018-2023)
Table 27. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Type (2024-2033)
Table 29. Global Psoriatic Arthritis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2018-2023)
Table 31. Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Application (2024-2033)
Table 33. North America Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Psoriatic Arthritis Therapeutics Product
Table 51. Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Bayer Company Detail
Table 54. Bayer Business Overview
Table 55. Bayer Psoriatic Arthritis Therapeutics Product
Table 56. Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 57. Bayer Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Psoriatic Arthritis Therapeutics Product
Table 61. Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Abbott Laboratories Company Detail
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Psoriatic Arthritis Therapeutics Product
Table 66. Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Sanofi Company Detail
Table 69. Sanofi Business Overview
Table 70. Sanofi Psoriatic Arthritis Therapeutics Product
Table 71. Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Bristol-Myers Squibb Company Detail
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product
Table 76. Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Janssen Biotech Company Detail
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Psoriatic Arthritis Therapeutics Product
Table 81. Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Janssen Biotech Recent Development
Table 83. Amgen Company Detail
Table 84. Amgen Business Overview
Table 85. Amgen Psoriatic Arthritis Therapeutics Product
Table 86. Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Amgen Recent Development
Table 88. UCB Company Detail
Table 89. UCB Business Overview
Table 90. UCB Psoriatic Arthritis Therapeutics Product
Table 91. UCB Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 92. UCB Recent Development
Table 93. AbbVie Company Detail
Table 94. AbbVie Business Overview
Table 95. AbbVie Psoriatic Arthritis Therapeutics Product
Table 96. AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2018-2023) & (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriatic Arthritis Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Psoriatic Arthritis Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Nonsteroidal Anti-Inflammatory Drug Features
Figure 4. Disease-Modifying Antirheumatic Drug Features
Figure 5. Biologic Drug Features
Figure 6. Enzyme Inhibitor Features
Figure 7. Global Psoriatic Arthritis Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Psoriatic Arthritis Therapeutics Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Research Labs Case Studies
Figure 12. Psoriatic Arthritis Therapeutics Report Years Considered
Figure 13. Global Psoriatic Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Psoriatic Arthritis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Psoriatic Arthritis Therapeutics Market Share by Region: 2022 VS 2033
Figure 16. Global Psoriatic Arthritis Therapeutics Market Share by Players in 2022
Figure 17. Global Top Psoriatic Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Revenue in 2022
Figure 19. North America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Psoriatic Arthritis Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis Therapeutics Market Share by Country (2018-2033)
Figure 25. Germany Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis Therapeutics Market Share by Region (2018-2033)
Figure 33. China Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis Therapeutics Market Share by Country (2018-2033)
Figure 41. Mexico Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis Therapeutics Market Share by Country (2018-2033)
Figure 45. Turkey Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Psoriatic Arthritis Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 48. Bayer Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 50. Abbott Laboratories Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 53. Janssen Biotech Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 54. Amgen Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 55. UCB Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 56. AbbVie Revenue Growth Rate in Psoriatic Arthritis Therapeutics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed